Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Clovis Is Said to Get No Interest After Seeking Buyers
Bloomberg
Tuesday, September 24, 2013 - 6:03pm
tags:
Clovis Oncology, M&A
Insiders Are Selling Biogen Idec
Seeking Alpha
Tuesday, September 24, 2013 - 5:57pm
tags:
Biogen Idec, AbbVie, Amgen, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Cephalon
Novavax raising $82.6M from stock offering
Yahoo/AP
Tuesday, September 24, 2013 - 11:15am
tags:
Novavax, stock offering
GlaxoSmithKline's China sales set for 30% hit, analysts figure
Fierce Pharma
Tuesday, September 24, 2013 - 11:13am
tags:
GSK, China
Who are the richest biopharma execs? Not all the usual suspects
Fierce Pharma
Tuesday, September 24, 2013 - 11:12am
tags:
executive pay, Regeneron
Medical Device’s Slow Growth Forces Search for New Areas
Bloomberg
Tuesday, September 24, 2013 - 11:09am
tags:
devices
After cutting jobs, Sequenom says it will consider strategic options for research business
Yahoo/AP
Tuesday, September 24, 2013 - 11:05am
tags:
Sequenom
Teva announces launch of generic Adenoscan in U.S.
The Fly on the Wall
Tuesday, September 24, 2013 - 11:03am
tags:
Teva, Adenoscan, generics
Vascepa Scripts Keep Screaming For Amarin
Seeking Alpha
Tuesday, September 24, 2013 - 10:54am
tags:
Vascepa, Amarin
Physicians' preferences on live drug rep details vs. alternative detailing methods
Pharmalot
Tuesday, September 24, 2013 - 10:24am
tags:
drug reps, detailing, physicians
Why This Big Pharma Is a Health Care Industry Star
Motley Fool
Tuesday, September 24, 2013 - 10:22am
tags:
JNJ
AbbVie and Galapagos enter into alliance to develop cystic fibrosis therapies
The Fly on the Wall
Tuesday, September 24, 2013 - 10:17am
tags:
AbbVie, Galapgos, cystic fibrosis
A Novartis -- Roche Merger? Say It Isn't So!
Forbes
Tuesday, September 24, 2013 - 10:14am
tags:
Novartis, Roche, M&A
Bristol-Myers, AstraZeneca diabetes drug delivers improvement for patients in late-stage study
Yahoo/AP
Tuesday, September 24, 2013 - 10:13am
tags:
Bristol-Myers Squibb, diabetes, AstraZeneca, Dapagliflozin
Why Pfizer And Publix Will Ramp Up Acura Pharmaceuticals
Seeking Alpha
Tuesday, September 24, 2013 - 10:12am
tags:
Pfizer, Acura Pharmaceuticals
Drug Development Risk #364: Poorly Run Clinical Trials
Motley Fool
Tuesday, September 24, 2013 - 10:10am
tags:
R&D, clinical trials, Merck, Vertex Pharmaceuticals, Peregrine Pharmaceuticals, JNJ, Bridion
Eli Lilly presents data from post-hoc analyses of linagliptin
Yahoo/Fly on the Wall
Tuesday, September 24, 2013 - 10:09am
tags:
Eli Lilly, linagliptin, Boehringer Ingelheim, diabetes
Bind Therapeutics - Cancer Research IPOs Are The Hottest Things In Town
Seeking Alpha
Tuesday, September 24, 2013 - 10:07am
tags:
Bind Therapeutics, cancer, IPOs
Why Can't This Company Get Its Act Together?
Motley Fool
Monday, September 23, 2013 - 3:56pm
tags:
JNJ, recalls
J&J, FDA And Their Tussle Over Tylenol And Liver Damage
Pharmalot
Monday, September 23, 2013 - 3:36pm
tags:
FDA, Tylenol, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.